Total Payments
$252.67
2024 Payments
$197.06
Companies
5
Transactions
9
Medicare Patients
6,062
Medicare Billing
$978,435
Payment Breakdown by Category
Food & Beverage$252.67 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $252.67 | 9 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $125.00 | 1 | $0 (2024) |
| Philips North America LLC | $72.06 | 4 | $0 (2024) |
| GlaxoSmithKline, LLC. | $24.80 | 2 | $0 (2020) |
| Philips Electronics North America Corporation | $19.09 | 1 | $0 (2023) |
| Allergan Inc. | $11.72 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $197.06 | 5 | AstraZeneca Pharmaceuticals LP ($125.00) |
| 2023 | $19.09 | 1 | Philips Electronics North America Corporation ($19.09) |
| 2020 | $13.67 | 1 | GlaxoSmithKline, LLC. ($13.67) |
| 2018 | $11.13 | 1 | GlaxoSmithKline, LLC. ($11.13) |
| 2017 | $11.72 | 1 | Allergan Inc. ($11.72) |
All Payment Transactions
9 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $19.31 | General |
| Category: Medical Device | ||||||
| 11/12/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.68 | General |
| Category: Medical Device | ||||||
| 09/13/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $17.30 | General |
| Category: Medical Device | ||||||
| 04/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Respiratory | ||||||
| 01/10/2024 | Philips North America LLC | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $17.77 | General |
| Category: Medical Device | ||||||
| 12/06/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $19.09 | General |
| Category: Medical Device | ||||||
| 02/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2018 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: RESPIRATORY | ||||||
| 12/18/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 1,287 | 2,134 | $536,510 | $176,119 |
| 2022 | 20 | 1,578 | 3,208 | $906,688 | $254,887 |
| 2021 | 21 | 1,635 | 3,199 | $944,586 | $268,339 |
| 2020 | 18 | 1,562 | 3,215 | $1.0M | $279,089 |
Total Patients
6,062
Total Services
11,756
Medicare Billing
$978,435
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99350 | Residence visit for established patient with high level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 32 | 195 | $116,145 | $31,649 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 140 | 301 | $130,530 | $30,058 | 23.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 146 | 258 | $88,520 | $26,685 | 30.1% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 106 | 144 | $26,355 | $20,096 | 76.3% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 41 | 219 | $18,204 | $12,633 | 69.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 43 | 145 | $15,106 | $11,448 | 75.8% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 27 | 66 | $28,035 | $6,960 | 24.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 39 | 41 | $26,170 | $6,146 | 23.5% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2023 | 48 | 52 | $6,500 | $5,096 | 78.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 52 | $12,245 | $3,521 | 28.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 13 | 18 | $16,845 | $3,316 | 19.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 24 | $3,600 | $2,822 | 78.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 28 | 32 | $3,360 | $2,634 | 78.4% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 17 | 19 | $2,850 | $2,234 | 78.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 31 | 31 | $3,410 | $2,230 | 65.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $6,780 | $1,537 | 22.7% |
| 94375 | Test to measure rate of airflow | Facility | 2023 | 104 | 105 | $5,250 | $1,232 | 23.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 34 | 34 | $3,545 | $1,155 | 32.6% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 107 | 108 | $4,320 | $1,066 | 24.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 13 | 14 | $3,850 | $881.91 | 22.9% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 107 | 108 | $3,240 | $791.44 | 24.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 13 | $4,020 | $751.75 | 18.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 15 | 17 | $5,270 | $712.19 | 13.5% |
| 94200 | Test to measure largest amount of air breathed in an out | Facility | 2023 | 107 | 108 | $1,460 | $242.32 | 16.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 18 | $900.00 | $222.19 | 24.7% |
About Dr. Edward Mezic, MD
Dr. Edward Mezic, MD is a Pulmonary Disease healthcare provider based in Old Bridge, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1437218435.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Edward Mezic, MD has received a total of $252.67 in payments from pharmaceutical and medical device companies, with $197.06 received in 2024. These payments were reported across 9 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($252.67).
As a Medicare-enrolled provider, Mezic has provided services to 6,062 Medicare beneficiaries, totaling 11,756 services with total Medicare billing of $978,435. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Old Bridge, NJ
- Active Since 12/06/2006
- Last Updated 05/18/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1437218435
Products in Payments
- TEZSPIRE (Biological) $125.00
- (AK6) Vest Therapy (Device) $54.29
- (8874) inCourage (Device) $36.86
- TRELEGY ELLIPTA (Drug) $24.80
- VRAYLAR (Drug) $11.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Old Bridge
Joseph Mathew, Md, MD
Pulmonary Disease — Payments: $3,932
Pulmonary Disease $3,932
Edward Lee, M.d, M.D
Pulmonary Disease — Payments: $1,489
Pulmonary Disease $1,489
Kishore Ratkalkar, Md, MD
Pulmonary Disease — Payments: $216.78
Pulmonary Disease $216.78
Dr. Raj Dhakhwa, M.d, M.D
Pulmonary Disease — Payments: $32.78
Pulmonary Disease $32.78